Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

869.9500 37.30 (4.48%)

NSE Jun 25, 2025 12:47 PM

48.06% Fall from 52W High

Volume: 810.6K

Strides Pharma Science Ltd.

10 May 2024

869.95

4.48%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800mg

More from Strides Pharma Science Ltd.

Recommended

Market trades higher, KEC International bags orders worth Rs 1,236 crore for residential projects

Trendlyne Marketwatch | 25 Jun 2025, 12:38PM

Five stocks to buy from analysts this week - June 25, 2025

The Baseline | 25 Jun 2025, 11:20AM

Earnings Call Transcript - Q1FY21 for Strides Pharma Science